Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2004460355;60356;60357 chr2:178591689;178591688;178591687chr2:179456416;179456415;179456414
N2AB1840355432;55433;55434 chr2:178591689;178591688;178591687chr2:179456416;179456415;179456414
N2A1747652651;52652;52653 chr2:178591689;178591688;178591687chr2:179456416;179456415;179456414
N2B1097933160;33161;33162 chr2:178591689;178591688;178591687chr2:179456416;179456415;179456414
Novex-11110433535;33536;33537 chr2:178591689;178591688;178591687chr2:179456416;179456415;179456414
Novex-21117133736;33737;33738 chr2:178591689;178591688;178591687chr2:179456416;179456415;179456414
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAG
  • RefSeq wild type template codon: TTC
  • Domain: Fn3-33
  • Domain position: 68
  • Structural Position: 102
  • Q(SASA): 0.3617
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/E rs1223532991 -0.229 0.999 N 0.527 0.382 0.258779203287 gnomAD-2.1.1 4.02E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.88E-06 0
K/E rs1223532991 -0.229 0.999 N 0.527 0.382 0.258779203287 gnomAD-4.0.0 1.5919E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85961E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.4754 ambiguous 0.4538 ambiguous -0.718 Destabilizing 0.999 D 0.602 neutral None None None None N
K/C 0.6627 likely_pathogenic 0.678 pathogenic -0.513 Destabilizing 1.0 D 0.693 prob.neutral None None None None N
K/D 0.7283 likely_pathogenic 0.7268 pathogenic -0.466 Destabilizing 1.0 D 0.67 neutral None None None None N
K/E 0.2593 likely_benign 0.2533 benign -0.336 Destabilizing 0.999 D 0.527 neutral N 0.443559756 None None N
K/F 0.8314 likely_pathogenic 0.8245 pathogenic -0.234 Destabilizing 1.0 D 0.703 prob.neutral None None None None N
K/G 0.5801 likely_pathogenic 0.5698 pathogenic -1.116 Destabilizing 1.0 D 0.642 neutral None None None None N
K/H 0.3122 likely_benign 0.3189 benign -1.458 Destabilizing 1.0 D 0.651 neutral None None None None N
K/I 0.5076 ambiguous 0.4678 ambiguous 0.335 Stabilizing 1.0 D 0.693 prob.neutral None None None None N
K/L 0.4797 ambiguous 0.4802 ambiguous 0.335 Stabilizing 1.0 D 0.642 neutral None None None None N
K/M 0.2637 likely_benign 0.2628 benign 0.251 Stabilizing 1.0 D 0.647 neutral N 0.483771582 None None N
K/N 0.4347 ambiguous 0.4252 ambiguous -0.665 Destabilizing 1.0 D 0.659 neutral N 0.465263179 None None N
K/P 0.9818 likely_pathogenic 0.9836 pathogenic 0.014 Stabilizing 1.0 D 0.643 neutral None None None None N
K/Q 0.14 likely_benign 0.1359 benign -0.669 Destabilizing 1.0 D 0.639 neutral N 0.466263257 None None N
K/R 0.0937 likely_benign 0.095 benign -0.823 Destabilizing 0.999 D 0.536 neutral N 0.465953826 None None N
K/S 0.4939 ambiguous 0.4646 ambiguous -1.241 Destabilizing 0.999 D 0.578 neutral None None None None N
K/T 0.264 likely_benign 0.2444 benign -0.9 Destabilizing 1.0 D 0.66 neutral N 0.408420101 None None N
K/V 0.4201 ambiguous 0.3904 ambiguous 0.014 Stabilizing 1.0 D 0.661 neutral None None None None N
K/W 0.8647 likely_pathogenic 0.8647 pathogenic -0.142 Destabilizing 1.0 D 0.708 prob.delet. None None None None N
K/Y 0.7112 likely_pathogenic 0.7186 pathogenic 0.104 Stabilizing 1.0 D 0.677 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.